Banka BioLoo Ltd.

As of June 30, 2026, Banka BioLoo Ltd. carries a market capitalization of 980.58M, placing it among publicly traded companies globally. Its enterprise value stands at 980.58M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Banka BioLoo Ltd. has 10.39M shares outstanding.

As of June 30, 2026, Banka BioLoo Ltd. trades at a trailing price-to-earnings ratio of 303.38.

As of June 30, 2026, Banka BioLoo Ltd. trades at an EV/EBITDA multiple of 15.45 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.74 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 29.40 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 980.58M versus a market cap of 980.58M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 586,430.72 in revenue per employee across its workforce of 963.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Banka BioLoo Ltd. recorded an income tax benefit of -5.77M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -2.25M and 3.57M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Banka BioLoo Ltd.'s stock has declined approximately 28.57% over the past 52 weeks. The 50-day moving average sits at 75.51, while the 200-day moving average is 74.01.

Over the twelve months ended June 30, 2026, Banka BioLoo Ltd. generated 565.03M in revenue and converted that into 3.57M in net income, yielding earnings per share of 0.31. EBITDA reached 63.46M, while operating income came in at 36.30M.

Over the twelve months ended June 30, 2026, Banka BioLoo Ltd. posted a gross margin of 76.95, reflecting its pricing power and cost economics. The operating margin of 6.42 and net profit margin of 0.63 provide insight into operational efficiency.

Banka BioLoo Ltd.'s most recent stock split took place on September 8, 2020 with a 2:5 split ratio.